Dollar General Corporation (NYSE:DG): Bank of America Merrill Lynch stated that Dollar General is still implementing retail invitations and expanding product assortment. The firm keeps expecting market shares gains, and it keeps its Buy rating on the stock. Dollar General also intends to sell 30 million shares tonight in a secondary offering.
Cepheid (NASDAQ:CPHD) is believed by Piper Jaffray to be in a favorable positioned for growth after its analyst day, and the firm recommends using today’s pullback as an opportunity to buy.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Charles River Laboratories International, Inc. (NYSE:CRL) is believed by Sterne to have ongoing share gains in the outsourced preclinical market, and the firm believes that 2H 2012 results should be well above 1H 2012. The firm claims they would be aggressive buyers of shares, and it keeps its Buy rating and $45 price target on the stock.
Boston Scientific Corporation (NYSE:BSX) FY12 adjusted EPS estimate has been reduced by Argus to 43c from 45c, due to the company’s ongoing trend of its decreasing market share in drug-eluting stents and defibrillators. Argus believes that the company has been losing share to Medtronic (NYSE:MDT) in both categories. Argus keeps a Hold rating on the stock.
First Solar, Inc. (NASDAQ:FSLR): According to Axiom Capital, First Solar is not the owner of the PPA, instead, Nextara is, so the economics of this are not identical to other projects. The firm has stated that the EPS contribution is to be .32c, which is fully reflected in the stock.
Don’t Miss: Sharp: Don’t Blame Us For the iPhone 5 Shortage.